User profiles for Bertrand Lebouche
Bertrand LEBOUCHEAssociate professor, clinician researcher Research Institute McGill University health Centre Verified email at mcgill.ca Cited by 3639 |
[HTML][HTML] Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
…, I Bogoch, J Jollimore, G Lambert, B Lebouche… - Cmaj, 2017 - Can Med Assoc
Methods The guideline was developed by the Biomedical HIV Prevention Working Group of
the CIHR Canadian HIV Trials Network, with funding from the Canadian Institutes of Health …
the CIHR Canadian HIV Trials Network, with funding from the Canadian Institutes of Health …
[HTML][HTML] Telehealth and COVID-19 pandemic: an overview of the telehealth use, advantages, challenges, and opportunities during COVID-19 pandemic
The use of telehealth and digital health platforms has increased during the COVID-19 pandemic
due to the implementation of physical distancing measures and restrictions. To address …
due to the implementation of physical distancing measures and restrictions. To address …
Immunosuppressive tryptophan catabolism and gut mucosal dysfunction following early HIV infection
…, O Allam, A Ahmad, B Lebouché… - The Journal of …, 2015 - academic.oup.com
Background. Tryptophan (Trp) catabolism into kynurenine (Kyn) contributes to immune
dysfunction in chronic human immunodeficiency virus (HIV) infection. To better define the …
dysfunction in chronic human immunodeficiency virus (HIV) infection. To better define the …
Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients
É Vuille-Lessard, B Lebouché, L Lennox, JP Routy… - Aids, 2016 - journals.lww.com
Objective: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in
Western countries. HIV-infected persons without viral hepatitis are at increased risk of NAFLD. …
Western countries. HIV-infected persons without viral hepatitis are at increased risk of NAFLD. …
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis
T Pembroke, M Deschenes, B Lebouché… - Journal of …, 2017 - Elsevier
Background & Aims Hepatic steatosis (HS) seems common in patients infected with human
immunodeficiency virus (HIV). However, the relative effect of HIV, as well as hepatitis C virus (…
immunodeficiency virus (HIV). However, the relative effect of HIV, as well as hepatitis C virus (…
Circulating (1→ 3)-β-D-glucan is associated with immune activation during human immunodeficiency virus infection
…, CT Costiniuk, B Lebouché… - Clinical Infectious …, 2020 - academic.oup.com
Background Microbial translocation from the gut to systemic circulation contributes to immune
activation during human immunodeficiency virus (HIV) infection and is usually assessed …
activation during human immunodeficiency virus (HIV) infection and is usually assessed …
[HTML][HTML] Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A …
Background Direct acting antivirals (DAAs) have increased cure rates for hepatitis C virus (HCV)
infection; however, there are several obstacles to the uptake of DAAs in populations …
infection; however, there are several obstacles to the uptake of DAAs in populations …
[HTML][HTML] Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons
Background Vaccine uptake rates have been historically low in correctional settings. To better
understand vaccine hesitancy in these high-risk settings, we explored reasons for COVID-…
understand vaccine hesitancy in these high-risk settings, we explored reasons for COVID-…
Early initiation rather than prolonged duration of antiretroviral therapy in HIV infection contributes to the normalization of CD8 T-cell counts
…, JG Baril, R Leblanc, B Lebouche… - Clinical Infectious …, 2016 - academic.oup.com
Background. CD8 T-cell counts remain elevated in human immunodeficiency virus (HIV)
infection even after long-term antiretroviral therapy (ART), which is associated with an …
infection even after long-term antiretroviral therapy (ART), which is associated with an …
[HTML][HTML] HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets
R Song, I Lisovsky, B Lebouché, JP Routy… - PLoS …, 2014 - journals.plos.org
Carriage of the genetic combination encoding a high expression inhibitory Killer
Immunoglobulin-like Receptor (KIR)3DL1 with its ligand, HLA-B*57 (*h/*y+B*57) is associated with …
Immunoglobulin-like Receptor (KIR)3DL1 with its ligand, HLA-B*57 (*h/*y+B*57) is associated with …